Stonegate Oral Surgery, Llp - Medicare Dental Clinic in Rochester, NY

Stonegate Oral Surgery, Llp is a medicare enrolled dental clinic (Dentist - Oral And Maxillofacial Surgery) in Rochester, New York. The current practice location for Stonegate Oral Surgery, Llp is 2005 Lyell Ave, Suite 210, Rochester, New York. For appointments, you can reach them via phone at (585) 254-5360. The mailing address for Stonegate Oral Surgery, Llp is 2005 Lyell Ave, Suite 210, Rochester, New York and phone number is (585) 254-5360.

Stonegate Oral Surgery, Llp is licensed to practice in New York (license number 033748-1). The clinic also participates in the medicare program and its NPI number is 1194987008. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (585) 254-5360.

Contact Information

Stonegate Oral Surgery, Llp
2005 Lyell Ave
Suite 210
Rochester
NY 14606-2323
(585) 254-5360
Not Available

Dental Care Clinic Profile

Full NameStonegate Oral Surgery, Llp
SpecialityDentist
Location2005 Lyell Ave, Rochester, New York
Authorized Official Name and PositionAlan S Cassara (PARTNER)
Authorized Official Contact5852545360
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Stonegate Oral Surgery, Llp
2005 Lyell Ave
Suite 210
Rochester
NY 14606-2323

Ph: (585) 254-5360
Stonegate Oral Surgery, Llp
2005 Lyell Ave
Suite 210
Rochester
NY 14606-2323

Ph: (585) 254-5360

NPI Details:

NPI Number1194987008
Provider Enumeration Date07/01/2008
Last Update Date05/19/2015

Medicare PECOS Information:

Medicare PECOS PAC ID1658496419
Medicare Enrollment IDO20100916000624

News Archive

FibroGen receives FDA Orphan Drug Designation for FG-3019 to treat IPF

FibroGen, Inc., today announced that FG-3019, the Company's human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF).

Barr confirms UROXATRAL patent challenge

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.

Intense trauma can have long lasting effects on the brain and behavior of healthy people without causing a clinical disorder

Exposure to trauma may create enough changes in the brain to sensitize people to overreact to an innocuous facial gesture years later, even in people who don't have a stress-related disorder, says new research.

Surprising levels of mercury in Cincinnati's Brood-X cicadas

Think twice before you eat one of Cincinnati's Brood-X cicadas. That's the warning from researchers at the University of Cincinnati College of Engineering, who have found surprising levels of mercury in these insects.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Stonegate Oral Surgery, Llp such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1194987008NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1223S0112XDentist - Oral And Maxillofacial Surgery 033748-1 (New York)Primary
1223S0112XDentist - Oral And Maxillofacial Surgery 035902 (New York)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Stonegate Oral Surgery, Llp acts as a billing entity for following providers:
Provider NameAlan S Cassara
Provider TypePractitioner - Oral Surgery
Provider IdentifiersNPI Number: 1518172063
PECOS PAC ID: 0840316352
Enrollment ID: I20100921001512

News Archive

FibroGen receives FDA Orphan Drug Designation for FG-3019 to treat IPF

FibroGen, Inc., today announced that FG-3019, the Company's human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF).

Barr confirms UROXATRAL patent challenge

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.

Intense trauma can have long lasting effects on the brain and behavior of healthy people without causing a clinical disorder

Exposure to trauma may create enough changes in the brain to sensitize people to overreact to an innocuous facial gesture years later, even in people who don't have a stress-related disorder, says new research.

Surprising levels of mercury in Cincinnati's Brood-X cicadas

Think twice before you eat one of Cincinnati's Brood-X cicadas. That's the warning from researchers at the University of Cincinnati College of Engineering, who have found surprising levels of mercury in these insects.

Read more Medical News

› Verified 9 days ago

Provider NameWayne C Jarvis
Provider TypePractitioner - Oral Surgery
Provider IdentifiersNPI Number: 1316152879
PECOS PAC ID: 4981896289
Enrollment ID: I20101005000750

News Archive

FibroGen receives FDA Orphan Drug Designation for FG-3019 to treat IPF

FibroGen, Inc., today announced that FG-3019, the Company's human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF).

Barr confirms UROXATRAL patent challenge

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.

Intense trauma can have long lasting effects on the brain and behavior of healthy people without causing a clinical disorder

Exposure to trauma may create enough changes in the brain to sensitize people to overreact to an innocuous facial gesture years later, even in people who don't have a stress-related disorder, says new research.

Surprising levels of mercury in Cincinnati's Brood-X cicadas

Think twice before you eat one of Cincinnati's Brood-X cicadas. That's the warning from researchers at the University of Cincinnati College of Engineering, who have found surprising levels of mercury in these insects.

Read more Medical News

› Verified 9 days ago

News Archive

FibroGen receives FDA Orphan Drug Designation for FG-3019 to treat IPF

FibroGen, Inc., today announced that FG-3019, the Company's human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF).

Barr confirms UROXATRAL patent challenge

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.

Intense trauma can have long lasting effects on the brain and behavior of healthy people without causing a clinical disorder

Exposure to trauma may create enough changes in the brain to sensitize people to overreact to an innocuous facial gesture years later, even in people who don't have a stress-related disorder, says new research.

Surprising levels of mercury in Cincinnati's Brood-X cicadas

Think twice before you eat one of Cincinnati's Brood-X cicadas. That's the warning from researchers at the University of Cincinnati College of Engineering, who have found surprising levels of mercury in these insects.

Read more News

› Verified 9 days ago


Dental Clinics in Rochester, NY

Marc G. Johnson
Dental Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 150 Lynnwood Dr, Rochester, NY 14618
Phone: 585-472-6326    Fax: 585-922-4495
A Smile To Grow, Dentistry For Kids, Pllc
Dental Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 370 White Spruce Blvd, Rochester, NY 14623
Phone: 585-919-6624    
Mark A Lowenguth
Dental Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2024 W Henrietta Rd, Suite C, Rochester, NY 14623
Phone: 585-272-0120    Fax: 585-272-0123
Eastman Institute For Oral Health
Dental Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 60 Crittenden Blvd Apt 917, Rochester, NY 14620
Phone: 310-739-5718    
Twelve Corners Dentistry Pllc
Dental Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4 Chelmsford Rd, Rochester, NY 14618
Phone: 585-244-1177    
Periodontal Health Specialists
Dental Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1815 S Clinton Avenue, Suite 510, Rochester, NY 14618
Phone: 585-473-7600    Fax: 585-473-7653
Small To Tall, Dentistry For Children, Pllc
Dental Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3171 Chili Ave Ste 400, Rochester, NY 14624
Phone: 585-889-1290    Fax: 585-889-1345

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.